Lentiviral delivery of PPARγ shRNA alters the balance of osteogenesis and adipogenesis, improving bone microarchitecture

Tissue Engineering - Part A

Volumn 20, Issue 19-20, 2014, Pages 2699-2710

  James, Aaron W ^a,b   Shen, Jia ^b   Khadarian, Kevork ^b   Pang, Shen ^b   Chung, Greg ^b   Goyal, Raghav ^b   Asatrian, Greg ^b   Velasco, Omar ^b   Kim, Jung ^b   Zhang, Xinli ^b   Ting, Kang ^b   Soo, Chia ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTERIZED TOMOGRAPHY; CYTOLOGY; FATTY ACIDS; MAMMALS; OSTEOBLASTS; PHOSPHATASES; POLYMERASE CHAIN REACTION; PROTEINS; VETERINARY MEDICINE;

FATTY ACID-BINDING PROTEINS; IMMUNOHISTOCHEMICAL ANALYSIS; IMMUNOHISTOCHEMICAL STAINING; MICRO COMPUTED TOMOGRAPHY (MICRO-CT); PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION; TARTRATE-RESISTANT ACID PHOSPHATASE; TRABECULAR BONE ARCHITECTURE;

BONE;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; CATHEPSIN K; FAT DROPLET; FATTY ACID BINDING PROTEIN 4; LENTIVIRUS VECTOR; OSTEOCALCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SHORT HAIRPIN RNA; DIFFERENTIATION ANTIGEN; SMALL INTERFERING RNA;

ADIPOCYTE; ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE MARROW STROMA CELL; BONE METABOLISM; CELL TYPE; CONTROLLED STUDY; IMAGE RECONSTRUCTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIPID STORAGE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCID MOUSE; TRABECULAR BONE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BIOSYNTHESIS; CYTOLOGY; FEMUR; GENE EXPRESSION REGULATION; GENE TRANSFER; GENE VECTOR; GENETICS; LENTIVIRINAE; MALE; METABOLISM; OSTEOCLAST;

ADIPOGENESIS; ANIMALS; ANTIGENS, DIFFERENTIATION; FEMUR; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; LENTIVIRUS; MALE; MICE; MICE, SCID; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; PPAR GAMMA; RNA, SMALL INTERFERING;

EID: 84911943859     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0736     Document Type: Article

References (33)

1. Liu, Y., Song, C.Y., Wu, S.S., Liang, Q.H., Yuan, L.Q., and Liao, E.Y. Novel adipokines and bone metabolism. Int J Endocrinol 2013, 895045. 2013.
2. Sadie-Van Gijsen, H., Crowther, N.J., Hough, F.S., and Ferris, W.F. The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity. Cell Mol Life Sci 70, 2331, 2013.
3. Kawai, M., de Paula, F.J., and Rosen, C.J. New insights into osteoporosis: the bone-fat connection. J Intern Med 272, 317, 2012.
4. Doherty, A.L., Battaglino, R.A., Donovan, J., Gagnon, D., Lazzari, A.A., Garshick, E., et al. Adiponectin is a candidate biomarker of lower extremity bone density in men with chronic spinal cord injury. J Bone Miner Res 29, 251, 2014.
5. Tontonoz, P., and Spiegelman, B.M. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 77, 289, 2008.
6. Issemann, I., and Green, S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347, 645, 1990.
7. Gottlicher, M., Widmark, E., Li, Q., and Gustafsson, J.A. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci U S A 89, 4653, 1992.
8. Glass, C.K., Rose, D.W., and Rosenfeld, M.G. Nuclear receptor coactivators. Curr Opin Cell Biol 9, 222, 1997.
9. Chawla, A., and Lazar, M.A. Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival. Proc Natl Acad Sci U S A 91, 1786, 1994.
10. Adams, M., Montague, C.T., Prins, J.B., Holder, J.C., Smith, S.A., Sanders, L., et al. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest 100, 3149, 1997.
11. Imai, T., Takakuwa, R., Marchand, S., Dentz, E., Bornert, J.M., Messaddeq, N., et al. Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. Proc Natl Acad Sci U S A 101, 4543, 2004.
12. Rosen, E.D., Walkey, C.J., Puigserver, P., and Spiegelman, B.M. Transcriptional regulation of adipogenesis. Genes Dev 14, 1293, 2000.
13. Rosen, E.D., and MacDougald, O.A. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7, 885, 2006.
14. Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H., Yamauchi, T., Komeda, K., et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4, 597, 1999.
15. Barak, Y., Nelson, M.C., Ong, E.S., Jones, Y.Z., Ruiz-Lozano, P., Chien, K.R., et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4, 585, 1999.
16. Wahli, W. PPAR gamma: ally and foe in bone metabolism. Cell Metab 7, 188, 2008.
17. Kim, S.W., Her, S.J., Kim, S.Y., and Shin, C.S. Ectopic overexpression of adipogenic transcription factors induces transdifferentiation of MC3T3-E1 osteoblasts. Biochem Biophys Res Commun 327, 811, 2005.
18. Yoshiko, Y., Oizumi, K., Hasegawa, T., Minamizaki, T., Tanne, K., Maeda, N., et al. A subset of osteoblasts expressing high endogenous levels of PPARgamma switches fate to adipocytes in the rat calvaria cell culture model. PLoS One 5, e11782. 2010.
19. Takada, I., Suzawa, M., Matsumoto, K., and Kato, S. Suppression of PPAR transactivation switches cell fate of bone marrow stem cells from adipocytes into osteoblasts. Ann N Y Acad Sci 1116, 182, 2007.
20. Kawaguchi, H., Akune, T., Yamaguchi, M., Ohba, S., Ogata, N., Chung, U.I., et al. Distinct effects of PPARgamma insufficiency on bone marrow cells, osteoblasts, and osteoclastic cells. J Bone Miner Metab 23, 275, 2005.
21. Wan, Y., Chong, L.W., and Evans, R.M. PPAR-gamma regulates osteoclastogenesis in mice. Nat Med 13, 1496, 2007.
22. Wei, W., Wang, X., Yang, M., Smith, L.C., Dechow, P.C., Sonoda, J., et al. PGC1beta mediates PPARgamma activation of osteoclastogenesis and rosiglitazone-induced bone loss. Cell Metab 11, 503, 2010.
23. Wei, W., Zeve, D., Wang, X., Du, Y., Tang, W., Dechow, P.C., et al. Osteoclast progenitors reside in the peroxisome proliferator-activated receptor gamma-expressing bone marrow cell population. Mol Cell Biol 31, 4692, 2011.
24. Qin, X.F., An, D.S., Chen, I.S., and Baltimore, D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci U S A 100, 183, 2003.
25. Krishnan, A., Nair, S.A., and Pillai, M.R. Biology of PPAR gamma in cancer: a critical review on existing lacunae. Curr Mol Med 7, 532, 2007.
26. Schilling, T., Noth, U., Klein-Hitpass, L., Jakob, F., and Schutze, N. Plasticity in adipogenesis and osteogenesis of human mesenchymal stem cells. Mol Cell Endocrinol 271, 1, 2007.
27. Cinti, S. Transdifferentiation properties of adipocytes in the adipose organ. Am J Physiol Endocrinol Metab 297, E977, 2009.
28. Song, L., and Tuan, R.S. Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J 18, 980, 2004.
29. Slack, J.M., and Tosh, D. Transdifferentiation and metaplasia - switching cell types. Curr Opin Genet Dev 11, 581, 2001.
30. Miles, P.D., Barak, Y., and Evans, R.M. Metabolic characterization of mice heterozygous for PPARy deficiency. Diabetes 48:supplement 1, A68, 1999.
31. Akune, T., Ohba, S., Kamekura, S., Yamaguchi, M., Chung, U.I., Kubota, N., et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 113, 846, 2004.
32. Duque, G., Li, W., Vidal, C., Bermeo, S., Rivas, D., and Henderson, J. Pharmacological inhibition of PPARgamma increases osteoblastogenesis and bone mass in male C57BL/6 mice. J Bone Miner Res 28, 639, 2013.
33. Botolin, S., and McCabe, L.R. Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss. J Cell Physiol 209, 967, 2006.